Abstract
Chemotherapy kills cancer largely by damaging tumour DNA and preventing replication. It can be used for cure, symptom control, to reduce risks of recurrence or to make other cancer treatments such as radiotherapy more effective. Radiotherapy is the use of ionising radiation to kill cancers. It is usually given in multiple treatments (fractions) to minimise damage to normal tissue. Both modalities are widely used in the treatment of gynaecological cancers. This chapter deals with litigation related to their usage.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bissett D, Lamont DW, Nwabineli NJ, et al. The treatment of stage I carcinoma of the cervix in the west of Scotland 1980-1987. Br J Obstet Gynaecol. 1994;101:615–20.
Peters WA, Liu PY, Barrett RJ, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery on high-risk early-stage cancer of the cervix. J Clin Oncol. 2000;18:1606–13.
Green JA, Kirwan JM, Tierney JF, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet. 2001;358:781–6.
Vale CL, Tierney JF, Davidson SE, et al. Substantial improvement in UK cervical cancer survival with chemoradiotherapy: results of a Royal College of Radiologist’s audit. Clin Oncol. 2010;22:590–601.
Creutzberg CL, van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with Stage 1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Postoperative radiation therapy in endometrial carcinoma. Lancet. 2000;355:1404–11.
Nout RA, Smit VT, Putter H, et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority randomised trial. Lancet. 2010;375:816–23.
Johnson N, Cornes P. Survival and recurrent disease after postoperative radiotherapy for early endometrial cancer: systematic review and meta-analysis. BJOG. 2007;114:1313–20.
Hogberg T. Adjuvant chemotherapy in endometrial carcinoma: overview of randomised trials. Clin Oncol. 2008;20:463–9.
The International Collaborative Ovarian Neoplasm (ICON) group. Paclitaxel plus carboplatin versus standard chemotherapy with either single agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial. Lancet. 2002;360:505–15.
The ICON and AGO collaborators. Paclitaxel plus platinum based chemotherapy versus conventional platinum based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial. Lancet. 2003;361:2099–106.
Oza AM, Cook AD, Pfisterer J, et al. Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial. Lancet Oncol. 2015;16:928–36.
Moore DH, Thomas GM, Montana GS, et al. Preoperative chemoradiation for advanced vulval cancer: a phase II study of the Gynaecologic Oncology Group. Int J Radiat Oncol Biol Phys. 1998;42:79–85.
Homesley HD, Bundy BN, Sedlis A, et al. Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynaecol. 1986;68(6):733–40.
Kunos C, Simpkins F, Gibbons H, et al. Radiation therapy compared with pelvic node resection for node positive vulvar cancer: a randomized controlled trial. Obstet Gynecol. 2009;114(3):537–46.
Mahner S, Jueckstock J, Hilpert F, et al. Adjuvant therapy in lymph node positive vulvar cancer: the AGO-CaRE-1 study. J Natl Cancer Inst. 2015;107(3):dju426.
Harland S. Moving on after a serious untoward incident. Trends Urol Mens Health. 2013;4:33–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Symonds, P. (2018). Chemotherapy and Radiotherapy in Gynaecological Cancer. In: Jha, S., Ferriman, E. (eds) Medicolegal Issues in Obstetrics and Gynaecology. Springer, Cham. https://doi.org/10.1007/978-3-319-78683-4_70
Download citation
DOI: https://doi.org/10.1007/978-3-319-78683-4_70
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-78682-7
Online ISBN: 978-3-319-78683-4
eBook Packages: MedicineMedicine (R0)